Contrast-enhanced ultrasound features as a potential biomarker for the prediction of breast cancer recurrence
Ultraschall in der Medizin - European Journal of Ultrasound · 01.08.2025 · 46 (04) · 381-387
DOI: 10.1055/a-2333-7589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultraschall in der Medizin - European Journal of Ultrasound, erschienen am 01.08.2025. Verfasst von Youn Joo Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiology (Daejeon St. Mary's Hospital), The Catholic University of Korea College of Medicine, Seoul, Korea (the Republic of). Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Contrast Media, Ultrasonography, Mammary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: the National Research Foundation of Korea.
Abstract (Originalsprache)
To investigate the associations between contrast-enhanced ultrasound imaging features and disease recurrence among patients with locally advanced breast cancer treated with neoadjuvant chemotherapy. In the study, pre- and post-neoadjuvant chemotherapy contrast-enhanced ultrasound images of 43 patients with breast cancer were retrospectively analysed. Post-acquisition image processing involved the placement of freehand-drawn regions of interest, followed by the generation of blood flow kinetics representing blood volume and velocity for these regions of interest. Qualitative and quantitative contrast-enhanced ultrasound parameters were compared to predict recurrence, and receiver operating characteristic analysis was used to evaluate predictive ability. Among the 43 patients, 10 (23%) exhibited disease recurrence (median [range]: 27 [4–68] months). Post-neoadjuvant chemotherapy peak enhancement, wash-in area under the curve, wash-out area under the curve, and wash-in and wash-out area under the curve (p=0.003, p=0.004, p=0.026, and p=0.014, respectively) differed between the no-recurrence and recurrence groups. The area under the receiver operating characteristic curve (0.88; 95% confidence interval: 0.75–1.00) for post-neoadjuvant chemotherapy peak enhancement was the highest among the contrast-enhanced ultrasound parameters, with a cut-off of 13.33 arbitrary units. Higher peak enhancement on post-neoadjuvant chemotherapy contrast-enhanced ultrasound images was associated with recurrence in women with locally advanced breast cancer and is a potential biomarker of tumor recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Radiology (Daejeon St. Mary's Hospital), The Catholic University of Korea College of Medicine, Seoul, Korea (the Republic of).
- Radiology (Seoul St. Mary's Hospital), The Catholic University of Korea College of Medicine, Seoul, Korea (the Republic of).
- Radiology, National Cancer Center, Goyang, Korea (the Republic of).
ORCID-Profile: Youn Joo Lee, Sung Hun Kim
Förderung
- the National Research Foundation of Korea
Zitieren
APA
Lee, Y. J., Kim, S. H., Kang, B. J., & Kim, Y. J. (2025). Contrast-enhanced ultrasound features as a potential biomarker for the prediction of breast cancer recurrence. Ultraschall in der Medizin - European Journal of Ultrasound, 46(04), 381-387. https://doi.org/10.1055/a-2333-7589
Vancouver
Lee YJ, Kim SH, Kang BJ, Kim YJ. Contrast-enhanced ultrasound features as a potential biomarker for the prediction of breast cancer recurrence. Ultraschall in der Medizin - European Journal of Ultrasound. 2025;46(04):381-387. doi:10.1055/a-2333-7589
BibTeX
@article{Lee2025,
author = {Lee, Youn Joo and Kim, Sung Hun and Kang, Bong Joo and Kim, Yun Ju},
title = {Contrast-enhanced ultrasound features as a potential biomarker for the prediction of breast cancer recurrence},
journal = {Ultraschall in der Medizin - European Journal of Ultrasound},
year = {2025},
volume = {46},
number = {04},
pages = {381--387},
doi = {10.1055/a-2333-7589}
}
EUVIMED